PROVIDER PROFILE · NPI 1043209604
Devin GlassesPA-C
PRESCRIBING · PART D · 2024
Total Rx claims
31
Beneficiaries
—
Total drug cost
$181
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Meloxicam18 claims
Diclofenac Sodium13 claims
QUALITY · MIPS · 2024
Final MIPS score
78.2
Quality
61.1
Cost
81.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.13%
Group
CROSS-REFERENCE